Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell-mediated antitumor activity

Front Immunol. 2022 Dec 8:13:1093403. doi: 10.3389/fimmu.2022.1093403. eCollection 2022.

Hao Zheng^{1

2

3

4

5}, Wen-Juan Zheng¹, Zhen-Guang Wang^{3

4

5}, Yuan-Ping Tao⁶, Zhi-Ping Huang⁷, Le Yang⁶, Liu Ouyang⁸, Zhi-Qing Duan¹, Yi-Nuo Zhang¹, Bo-Ning Chen¹, Dai-Min Xiang⁹, Gang Jin⁸, Lu Fang¹, Fan Zhou¹, Bo Liang¹

¹ Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
² Department of Reproductive Heredity Center, Changhai Hospital, Second Military Medical University, Shanghai, China.
³ Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
⁴ Key Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer (SMMU), Ministry of Education, Shanghai, China.
⁵ Shanghai Key Laboratory of Hepatobiliary Tumor Biology (EHBH), Shanghai, China.
⁶ National Liver Tissue Bank, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
⁷ Department of Hepatobiliary Surgery, General Hospital of Southern Theatre Command, Guangzhou, China.
⁸ Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital of Second Military Medical University, Shanghai, China.
⁹ State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.845193.].

Keywords: METTL14; N6-methyladenosine; PD-L1; Siah2; immunotherapy.